MA55480A - Procédés de fabrication de vecteurs viraux recombinants - Google Patents

Procédés de fabrication de vecteurs viraux recombinants

Info

Publication number
MA55480A
MA55480A MA055480A MA55480A MA55480A MA 55480 A MA55480 A MA 55480A MA 055480 A MA055480 A MA 055480A MA 55480 A MA55480 A MA 55480A MA 55480 A MA55480 A MA 55480A
Authority
MA
Morocco
Prior art keywords
methods
viral vectors
recombinant viral
making recombinant
making
Prior art date
Application number
MA055480A
Other languages
English (en)
Inventor
Maria-Fatima Bosch-Tubert
Laura Cervera-Gracia
Miguel Garcia-Martinez
Francesc Godia-Casablancas
Sonia Gutierrez-Granados
Xavier Leon-Madrenas
Maria Molas-Laplana
Original Assignee
Esteve Pharmaceuticals Sa
UNIV AUTòNOMA DE BARCELONA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Pharmaceuticals Sa, UNIV AUTòNOMA DE BARCELONA filed Critical Esteve Pharmaceuticals Sa
Publication of MA55480A publication Critical patent/MA55480A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA055480A 2019-03-28 2020-03-26 Procédés de fabrication de vecteurs viraux recombinants MA55480A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19382220 2019-03-28

Publications (1)

Publication Number Publication Date
MA55480A true MA55480A (fr) 2022-02-09

Family

ID=66175374

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055480A MA55480A (fr) 2019-03-28 2020-03-26 Procédés de fabrication de vecteurs viraux recombinants

Country Status (14)

Country Link
US (1) US20220186255A1 (fr)
EP (1) EP3947654A1 (fr)
JP (1) JP2022527407A (fr)
KR (1) KR20210148227A (fr)
CN (1) CN114466926A (fr)
AR (1) AR118493A1 (fr)
AU (1) AU2020247133A1 (fr)
BR (1) BR112021019022A2 (fr)
CA (1) CA3134429A1 (fr)
IL (1) IL286475A (fr)
MA (1) MA55480A (fr)
MX (1) MX2021011741A (fr)
TW (1) TW202039856A (fr)
WO (1) WO2020193698A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7415042B2 (ja) * 2020-10-09 2024-01-16 テナヤ セラピューティクス， インコーポレイテッド プラコフィリン２遺伝子治療の方法および組成物
US11781156B2 (en) 2020-10-09 2023-10-10 Tenaya Therapeutics, Inc. Plakophillin-2 gene therapy methods and compositions
WO2023102736A1 (fr) * 2021-12-07 2023-06-15 中国科学院深圳先进技术研究院 Plasmide d'encapsidation de virus adéno-associé recombiné, virus adéno-associé recombiné et son application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622856A (en) * 1995-08-03 1997-04-22 Avigen High efficiency helper system for AAV vector production
US6509150B1 (en) * 1999-03-05 2003-01-21 Universite De Nantes Compositions and methods for recombinant Adeno-Associated Virus production
DE10056210A1 (de) * 2000-11-13 2002-05-29 Arimedes Biotechnology Gmbh Virales Expressionssystem
WO2004020600A2 (fr) * 2002-08-28 2004-03-11 University Of Florida Aav modifies
EP1771571A2 (fr) * 2004-07-30 2007-04-11 Targeted Genetics Corporation Procedes de vaccination a base d'aav recombine
EP2394667A1 (fr) * 2010-06-10 2011-12-14 Laboratorios Del Dr. Esteve, S.A. Vecteurs et séquences pour le traitement de maladies
CN105612253A (zh) * 2013-03-15 2016-05-25 费城儿童医院 含有填充者/填充物多核苷酸序列的载体及其制备方法
WO2014194132A1 (fr) * 2013-05-31 2014-12-04 The Regents Of The University Of California Variants de virus adéno-associés et leurs méthodes d'utilisation
EP3101125A1 (fr) * 2015-06-05 2016-12-07 Laboratorios Del Dr. Esteve, S.A. Vecteurs viraux recombinés adéno-associés pour le traitement de la mucopolysaccharidose

Also Published As

Publication number Publication date
IL286475A (en) 2021-10-31
BR112021019022A2 (pt) 2021-11-30
JP2022527407A (ja) 2022-06-01
WO2020193698A1 (fr) 2020-10-01
CN114466926A (zh) 2022-05-10
AU2020247133A1 (en) 2021-10-14
CA3134429A1 (fr) 2020-10-01
US20220186255A1 (en) 2022-06-16
KR20210148227A (ko) 2021-12-07
TW202039856A (zh) 2020-11-01
AR118493A1 (es) 2021-10-20
EP3947654A1 (fr) 2022-02-09
MX2021011741A (es) 2022-01-06

Similar Documents

Publication Publication Date Title
MA55480A (fr) Procédés de fabrication de vecteurs viraux recombinants
SG11202006498PA (en) Methods of assessing transduction potency of viral vectors
GB2573663B (en) Viral methods of making genetically modified cells
SG11202009009UA (en) Viral and non-viral nanoplasmid vectors with improved production
IL284217A (en) Automated production of viral vectors
GB201814590D0 (en) Viral vector production system
EP4061427A4 (fr) Variants de vecteurs viraux adéno-associés
IL304199A (en) Using cd8-targeted viral vectors
MA53498A (fr) Production de protéines recombinantes
DK3262024T3 (da) Fremgangsmåde til fremstilling af aminosyrer ud fra udgangsstoffer opnået ved anærob fermentering ud fra fermentérbar biomasse
IL288419A (en) Recombinant viral herpes vector
ES2970223T3 (es) Péptidos
IL280840A (en) Production methods for viral vectors
ZA202100242B (en) Recombinant nucleic acid construct
ZA202108996B (en) Viral vector
MA55912A (fr) Procédés de sélection auxotrophe
DK3818078T3 (da) Fremgangsmåder til fremstilling af rekombinante proteiner
IL288404A (en) Viral vector test with very high accuracy
EP4072582A4 (fr) Procédés de préparation de vecteurs viraux
GB202209861D0 (en) Viral vectors
GB202312083D0 (en) Viral vector
GB202211673D0 (en) Viral vector
GB202110510D0 (en) Viral vector
GB202017141D0 (en) Viral vector
GB202202090D0 (en) Viral vector production